Literature DB >> 18803607

Strategy to assess the overall cytokine profile of circulating leukocytes and its association with distinct clinical forms of human Chagas disease.

D M Vitelli-Avelar1, R Sathler-Avelar, A Teixeira-Carvalho, J C Pinto Dias, E D Gontijo, A M Faria, S M Elói-Santos, O A Martins-Filho.   

Abstract

Herein we have employed an alternative strategy to assess the cytokine patterns of circulating leukocytes and correlate dominant cytokine profiles with indeterminate-IND and cardiac-CARD clinical forms of Chagas disease. We have first calculated median percentages of cytokine-positive leukocytes of our study sample to establish, for each cytokine-positive cell population, the cut-off edge that would segregate 'low' and 'high' cytokine producers to build colour diagrams and draw a panoramic cytokine chart. Using this approach we demonstrated that most IND individuals presented a dominant regulatory cytokine profile, whereas CARD individuals displayed a dominant inflammatory cytokine pattern. In addition, radar chart analysis confirmed the dichotomic cytokine balance between IND and CARD groups and further allowed the identification of the relative contribution of each cell population for the global cytokine pattern. Data analysis demonstrated that CD4+ T cells were the major cell population defining the regulatory profile in IND, whereas monocytes and CD4+ T cells determined the inflammatory cytokine pattern in CARD individuals. Interestingly, in vitro stimulation with trypomastigote Trypanosoma cruzi antigen was able to invert the cytokine balances in IND and CARD groups. Upon antigenic stimulation, changes in the frequencies of IL-10-producing CD4+ T cells and monocytes drove IND individuals towards an inflammatory pattern and CARD towards a regulatory cytokine profile. A similar inversion could be found after in vivo treatment of IND and CARD individuals with benzonidazole. Altogether, these findings shed some light into the complex cytokine network underlying the immunopathogenesis of Chagas disease and provide putative immunological biomarkers of disease severity and therapeutic response.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18803607     DOI: 10.1111/j.1365-3083.2008.02167.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  26 in total

Review 1.  Immunoregulatory networks in human Chagas disease.

Authors:  W O Dutra; C A S Menezes; L M D Magalhães; K J Gollob
Journal:  Parasite Immunol       Date:  2014-08       Impact factor: 2.280

2.  T-Cell Immunophenotyping and Cytokine Production Analysis in Patients with Chagas Disease 4 Years after Benznidazole Treatment.

Authors:  Mauricio Llaguno; Marcos Vinicius da Silva; Lara Rocha Batista; Djalma Alexandre Alves da Silva; Rodrigo Cunha de Sousa; Luiz Antonio Pertili Rodrigues de Resende; Valdo Jose Dias da Silva; Eliane Lages-Silva; Carlo José Freire Oliveira; Juliana Reis Machado; Denise Bertulucci Rocha Rodrigues; Dalmo Correia; Virmondes Rodrigues
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

3.  A shift towards a T cell cytokine deficiency along with an anti-inflammatory/regulatory microenvironment may enable the synthesis of anti-FVIII inhibitors in haemophilia A patients.

Authors:  D G Chaves; C Velloso-Rodrigues; C A Oliveira; A Teixeira-Carvalho; M M Santoro; O A Martins-Filho
Journal:  Clin Exp Immunol       Date:  2010-09-15       Impact factor: 4.330

4.  Increase in the expression of CD4 + CD25+ lymphocytic T cells in the indeterminate clinical form of human Chagas disease after stimulation with recombinant antigens of Trypanosoma cruzi.

Authors:  Suellen Carvalho de Moura Braz; Adriene Siqueira de Melo; Maria da Glória Aureliano de Melo Cavalcanti; Sílvia Marinho Martins; Wilson de Oliveira; Edimilson Domingos da Silva; Antonio Gomes Pinto Ferreira; Virginia Maria Barros de Lorena; Yara de Miranda Gomes
Journal:  J Clin Immunol       Date:  2014-09-10       Impact factor: 8.317

5.  Bone Marrow Soluble Mediator Signatures of Patients With Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.

Authors:  Juçara Gastaldi Cominal; Maira da Costa Cacemiro; Maria Gabriela Berzoti-Coelho; Illy Enne Gomes Pereira; Fabiani Gai Frantz; Elizabeth Xisto Souto; Dimas Tadeu Covas; Lorena Lobo de Figueiredo-Pontes; Maria Carolina Oliveira; Kelen Cristina Ribeiro Malmegrim; Fabíola Attié de Castro
Journal:  Front Oncol       Date:  2021-05-18       Impact factor: 6.244

6.  Blood leukocytes from benznidazole-treated indeterminate chagas disease patients display an overall type-1-modulated cytokine profile upon short-term in vitro stimulation with Trypanosoma cruzi antigens.

Authors:  Renato Sathler-Avelar; Danielle Marquete Vitelli-Avelar; Silvana Maria Elói-Santos; Eliane Dias Gontijo; Andréa Teixeira-Carvalho; Olindo Assis Martins-Filho
Journal:  BMC Infect Dis       Date:  2012-05-24       Impact factor: 3.090

7.  Different infective forms trigger distinct immune response in experimental Chagas disease.

Authors:  Paula Melo de Abreu Vieira; Amanda Fortes Francisco; Evandro Marques de Meneses Machado; Nívia Carolina Nogueira; Kátia da Silva Fonseca; Alexandre Barbosa Reis; Andrea Teixeira-Carvalho; Olindo Assis Martins-Filho; Washington Luiz Tafuri; Cláudia Martins Carneiro
Journal:  PLoS One       Date:  2012-03-07       Impact factor: 3.240

Review 8.  Regulatory T cells phenotype in different clinical forms of Chagas' disease.

Authors:  Fernanda Fortes de Araújo; Danielle Marquete Vitelli-Avelar; Andréa Teixeira-Carvalho; Paulo Renato Antas; Juliana Assis Silva Gomes; Renato Sathler-Avelar; Manoel Otávio Costa Rocha; Silvana Maria Elói-Santos; Rosa Teixeira Pinho; Rodrigo Correa-Oliveira; Olindo Assis Martins-Filho
Journal:  PLoS Negl Trop Dis       Date:  2011-05-31

9.  HSP60: issues and insights on its therapeutic use as an immunoregulatory agent.

Authors:  Verônica Coelho; Ana M C Faria
Journal:  Front Immunol       Date:  2012-01-12       Impact factor: 7.561

10.  CD4+ CD25+ FOXP3+ Treg cells induced by rSSP4 derived from T. cruzi amastigotes increase parasitemia in an experimental Chagas disease model.

Authors:  Y Flores-García; J L Rosales-Encina; V H Rosales-García; A R Satoskar; P Talamás-Rohana
Journal:  Biomed Res Int       Date:  2012-12-26       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.